JP2019522046A5 - - Google Patents

Download PDF

Info

Publication number
JP2019522046A5
JP2019522046A5 JP2019517165A JP2019517165A JP2019522046A5 JP 2019522046 A5 JP2019522046 A5 JP 2019522046A5 JP 2019517165 A JP2019517165 A JP 2019517165A JP 2019517165 A JP2019517165 A JP 2019517165A JP 2019522046 A5 JP2019522046 A5 JP 2019522046A5
Authority
JP
Japan
Prior art keywords
lys
ser
asp
seq
thr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019517165A
Other languages
English (en)
Japanese (ja)
Other versions
JP7010934B2 (ja
JP2019522046A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2017/064196 external-priority patent/WO2017212057A1/en
Publication of JP2019522046A publication Critical patent/JP2019522046A/ja
Publication of JP2019522046A5 publication Critical patent/JP2019522046A5/ja
Application granted granted Critical
Publication of JP7010934B2 publication Critical patent/JP7010934B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019517165A 2016-06-10 2017-06-09 変形性関節症の治療のためのペプチド Expired - Fee Related JP7010934B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP16174056 2016-06-10
EP16174056.8 2016-06-10
PCT/EP2017/064196 WO2017212057A1 (en) 2016-06-10 2017-06-09 Peptides for the treatment of osteoarthritis

Publications (3)

Publication Number Publication Date
JP2019522046A JP2019522046A (ja) 2019-08-08
JP2019522046A5 true JP2019522046A5 (enExample) 2020-07-16
JP7010934B2 JP7010934B2 (ja) 2022-02-10

Family

ID=56132793

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019517165A Expired - Fee Related JP7010934B2 (ja) 2016-06-10 2017-06-09 変形性関節症の治療のためのペプチド

Country Status (12)

Country Link
US (1) US10813980B2 (enExample)
EP (1) EP3468582A1 (enExample)
JP (1) JP7010934B2 (enExample)
KR (1) KR20190018466A (enExample)
CN (1) CN109862905A (enExample)
AU (1) AU2017277747A1 (enExample)
BR (1) BR112018075613A2 (enExample)
CA (1) CA3026984A1 (enExample)
IL (1) IL263564B (enExample)
MA (1) MA45227A (enExample)
RU (1) RU2018145945A (enExample)
WO (1) WO2017212057A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108785661A (zh) * 2018-07-20 2018-11-13 深圳市第二人民医院 一种无副作用治疗退行性骨关节病的注射剂及其制备方法
IL280880B2 (en) 2018-08-27 2025-04-01 Regeneron Pharma Using Raman Spectroscopy in Downstream Purification
KR102856432B1 (ko) 2022-02-23 2025-09-08 중앙대학교 산학협력단 졸참나무 잎 추출물을 유효성분으로 포함하는 골관절염 예방 또는 치료용 조성물

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1208760B (it) * 1986-11-04 1989-07-10 Ind Farmaceutica Serono S P A Trattamento delle malattie infiammatorie articolari
FR2833012B1 (fr) * 2001-12-04 2004-01-30 Centre Nat Rech Scient Peptides agonistes de l'hormone de croissance et leurs applications
US20040127402A1 (en) * 2002-12-27 2004-07-01 Vad Vijay B. Injectible composition and method for treating degenerative animal joints
US7803781B2 (en) * 2003-02-28 2010-09-28 Isis Pharmaceuticals, Inc. Modulation of growth hormone receptor expression and insulin-like growth factor expression
US20070184015A1 (en) 2006-02-03 2007-08-09 Soonkap Hahn Novel PEGylation agent
CA2755436C (en) * 2009-03-19 2019-10-29 Claude Carelli Peptides for inhibiting igf-1
ES2616004T3 (es) * 2009-11-18 2017-06-09 Asahi Kasei Pharma Corporation Agente profiláctico y/o agente terapéutico y/o agente supresor de exacerbación para osteortritis de rodilla humana

Similar Documents

Publication Publication Date Title
RU2012140704A (ru) Способ профилактики и/или лечения фиброза и/или помутнения роговицы (варианты), способ получения фармацевтической композиции для профилактики и/или лечения фиброза и/или помутнения роговицы и глазная фармацевтическая композиция
RU2014126244A (ru) Лекарственные средства, содержащие аминокислотные последовательности инсулина
JP2018504901A5 (enExample)
IL308807B2 (en) Combination therapy for treating cancer
JP2019533722A5 (enExample)
RU2013139651A (ru) Новые соединения, влияющие на пищевое поведение
JP2011518179A5 (enExample)
RU2011100801A (ru) Конъюгаты для введения биологически активных соединений
JP2019522046A5 (enExample)
JP2020518287A5 (enExample)
TWI612965B (zh) 玻尿酸之用途及疼痛抑制用醫藥組成物
AU2016255020B2 (en) Short synthetic peptide for treatment and/or prophylaxis of autoimmune and inflammatory disorders
RU2016137289A (ru) Схема применения соединения fgf-18
EP4578461A3 (en) Methods of treating parkinsons disease by administration of apomorphine to an oral mucosa
RU2013146690A (ru) Циклические пептиды с антинеопластической и антиангионенной активностью
US11654178B2 (en) Cyclic prosaposin peptides and uses thereof
RU2018145945A (ru) Пептид для лечения остеоартрита, фармацевтическая композиция, лекарственное средство, единичная дозированная форма
US20200172587A1 (en) Hydrochloride salts of c5a receptor agonist peptides
TW201815410A (zh) 藥物之經黏膜吸收促進劑
JP6471366B2 (ja) インクレチンホルモン又はそのアナログを用いた変形性関節症の処置
KR102568272B1 (ko) Ｇｌｐ-1ｒ 항체 융합 단백질의 안정한 약제학적 용액 제형
RU2711161C2 (ru) Циклический с-концевой пептид ацетилхолинэстеразы в лечении или предупреждении рака или метастазирования
CN107847452A (zh) 应答选择性C5a激动剂EP67的构象稳定类似物
EP3212219A1 (en) New indication for alpha-msh analogues
CN1824296A (zh) 芋螺多肽衍生物用于制备戒毒药物的用途